Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients Source: Annual Congress 2005 - Control of breathing Year: 2005
Recovery period after exercise in obstructive sleep apnea patients Source: Eur Respir J 2003; 22: Suppl. 45, 184s Year: 2003
Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy Source: Eur Respir J, 52 (3) 1800674; 10.1183/13993003.00674-2018 Year: 2018
Effect of nasal CPAP therapy on functional respiratory parameters and cardiopulmonary exercise test in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002
Efficacy of daytime continuous positive airway pressure titration in severe obstructive sleep apnoea Source: Eur Respir J 2001; 18: 535-541 Year: 2001
Spirometry and nocturnal oxygen saturation in patients with obstructive sleep apnoea with and without COPD Source: Eur Respir J 2005; 26: Suppl. 49, 568s Year: 2005
Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Evaluation of submaximal exercise capacity in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
What is the minimum duration of nocturnal oximetry to screen for obstructive sleep apnoea in children? Source: International Congress 2017 – What is new in respiratory and sleep physiology? Year: 2017
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy Source: Eur Respir J, 50 (5) 1700348; 10.1183/13993003.00348-2017 Year: 2017
Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002
Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019
Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
Daytime sleepiness in patients with treated obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 594s Year: 2007
Assessing an auto set trial period for obstructive sleep apnoea patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018